TCR² plants its flag in former Autolus manufacturing site, planning to add 175 jobs as it advances lead T cell therapy
Just months after London-based Autolus Therapeutics announced it would let go of 20% of its staffers as it looked for a partner for a lead …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
